Literature DB >> 19544494

IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.

Gabor Gyülvészi1, Stefan Haak, Burkhard Becher.   

Abstract

IL-23 but not IL-12 is essential for the development of autoimmune tissue inflammation in mice. Conversely, IL-12 and IL-23 impact on the polarization of Th1 and Th17 cells, respectively. While both polarized T helper populations can mediate autoimmune inflammation, their redundancy in the pathogenesis of EAE indicates that IL-23 exerts its crucial influence on the disease independent of its T helper polarizing capacity. To study the impact of IL-23 and IL-12 on the behavior of encephalitogenic T cells in vivo, we generated BM-chimeric mice in which we can trace individual populations of IL-23 or IL-12 responsive T helper cells during EAE. We observed that T cells, which lack IL-12Rbeta1 (no IL-12 and IL-23 signaling), fail to invade the CNS and do not acquire a Th17 phenotype. In contrast, loss of IL-12 signaling prevents Th1 polarization but does not prevent T-cell entry into the CNS. The loss of IL-12R engagement does not appear to alter T-cell expansion but leads to their accumulation in secondary lymphoid organs. We found that IL-23 licenses T cells to invade the target tissue and to exert their effector function, whereas IL-12 is critical for Th1 differentiation, but does not influence the pathogenic capacity of auto-reactive T helper cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544494     DOI: 10.1002/eji.200939305

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

Authors:  Laura Codarri; Gabor Gyülvészi; Vinko Tosevski; Lysann Hesske; Adriano Fontana; Laurent Magnenat; Tobias Suter; Burkhard Becher
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

Review 2.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer.

Authors:  S Reppert; I Boross; M Koslowski; Ö Türeci; S Koch; H A Lehr; S Finotto
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

4.  Preparation, crystallization and preliminary X-ray diffraction studies of the glycosylated form of human interleukin-23.

Authors:  Takumi Shirouzono; Mami Chirifu; Chiharu Nakamura; Yuriko Yamagata; Shinji Ikemizu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-03-27

5.  γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism.

Authors:  Franziska Petermann; Veit Rothhammer; Malte C Claussen; Jan D Haas; Lorena Riol Blanco; Sylvia Heink; Immo Prinz; Bernhard Hemmer; Vijay K Kuchroo; Mohamed Oukka; Thomas Korn
Journal:  Immunity       Date:  2010-09-09       Impact factor: 31.745

Review 6.  Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Authors:  Monojit Debnath; Michael Berk
Journal:  Schizophr Bull       Date:  2014-04-07       Impact factor: 9.306

7.  A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?

Authors:  Elfi Vergaelen; Carmen Schiweck; Kristof Van Steeland; Jacqueline Counotte; Wim Veling; Ann Swillen; Hemmo Drexhage; Stephan Claes
Journal:  Brain Behav Immun       Date:  2018-03-19       Impact factor: 7.217

Review 8.  T(H)17 cytokines in autoimmune neuro-inflammation.

Authors:  Burkhard Becher; Benjamin M Segal
Journal:  Curr Opin Immunol       Date:  2011-09-09       Impact factor: 7.486

9.  Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.

Authors:  Sangmu Jun; Javier Ochoa-Repáraz; Dagmara Zlotkowska; Teri Hoyt; David W Pascual
Journal:  J Neuroimmunol       Date:  2012-03-13       Impact factor: 3.478

10.  Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.

Authors:  Saravanan Kanakasabai; Wanida Chearwae; Crystal C Walline; Wade Iams; Suzanne M Adams; John J Bright
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.